Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „ADCETRIS“
Suchtreffer
Begriffe & Kennungen
Adcetris · 4.8 · In the pivotal phase 2 population (SG035-0003 and SG035-0004), the median duration of Grade 3 or Grade 4 neutr
Eintrag öffnenAdcetris · 4.8 · In the pooled dataset of ADCETRIS as monotherapy across HL, sALCL and CTCL studies (SG035-0003, SG035-0004, SG
Eintrag öffnenAdcetris · 4.8 · In the studies of ADCETRIS as combination therapy in 662 patients with previously untreated advanced HL (C2500
Eintrag öffnenAdcetris · 4.8 · Infusion-related reactions
Eintrag öffnenAdcetris · 4.8 · Monotherapy
Eintrag öffnenAdcetris · 4.8 · Monotherapy Study C25002
Eintrag öffnenAdcetris · 4.8 · Neutropenia and febrile neutropenia
Eintrag öffnenAdcetris · 4.8 · Paediatric population
Eintrag öffnenAdcetris · 4.8 · Peripheral neuropathy
Eintrag öffnenAdcetris · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAdcetris · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAdcetris · 4.8 · Safety was evaluated in a phase 1/2 study in paediatric patients aged 7-17 years of age (n = 36) with relapsed
Eintrag öffnenAdcetris · 4.8 · Safety was evaluated in an open-label, multicentre trial in 59 paediatric patients aged 6-17 years of age with
Eintrag öffnenAdcetris · 4.8 · Serious adverse drug reactions occurred in 12% of patients. The frequency of unique serious adverse drug react
Eintrag öffnenAdcetris · 4.8 · Serious adverse events led to treatment discontinuation in 2% of patients in both BrECADD and eBEACOPP arms. T
Eintrag öffnenAdcetris · 4.8 · Serious adverse reactions occurred in 39.4% patients receiving BrECADD treatment, and 36.4% in patients who re
Eintrag öffnenAdcetris · 4.8 · Serious cardiac adverse reactions occurred in 2.7% of patients receiving BrECADD and 1.1% of patients receivin
Eintrag öffnenAdcetris · 4.8 · Serious infections and opportunistic infections
Eintrag öffnenAdcetris · 4.8 · Severe and prolonged (≥ 1 week) neutropenia can occur with this treatment which may increase the risk of patie
Eintrag öffnenAdcetris · 4.8 · Summary of the safety profile
Eintrag öffnen